GSTP1 and prostate carcinoma: Promoter hypermethylation-mediated silencing of GSTP1 is only detected in intraepithelial neoplasia, prostatic adenocarcinoma, and fluids (plasma, serum, ejaculate, and urine) of patients with prostate cancer but is never detected in benign epithelium [9, 11–13].